Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents

BACKGROUND: With advent of direct-acting antiviral agents (DAA), hepatitis C virus (HCV) treatment is dramatically increasing. Although few studies reported rates of hepatocellular carcinoma (HCC) recurrence following DAA treatment, there have been no studies that followed sufficient number of DAA-t...

全面介紹

Na minha lista:
書目詳細資料
發表在:Dig Dis Sci
Main Authors: Zou, Winnie Y., Choi, Kati, Kramer, Jennifer R., Yu, Xian, Cao, Yumei, El-Serag, Hashem B., Kanwal, Fasiha
格式: Artigo
語言:Inglês
出版: 2019
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6819241/
https://ncbi.nlm.nih.gov/pubmed/31041639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-019-05641-3
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍